SPOTLIGHT -
Increase in the incidence rate of conjunctival melanoma in Australia
Investigators analysed the incidence and mortality rates from conjunctival melanoma cases over a 32-year period
How amyloid-beta peptide and tau protein demonstrate degeneration
Proteins common to Alzheimer disease play a significant role in glaucoma
Assessing long-term impact of ocular injuries after motor vehicle accidents
Researchers investigated patients' ability to drive and work following eye injury
COPHy 2024: Should all elderly patients with acute visual loss go to the emergency department?
A case study emphasises the shifting paradigm in clinical best practices
COPHy 2024: Intraocular inflammation as a risk factor resulting from use of anti-complement agents for GA
Good news for patients: use of anti-complement therapies have caused the growth rate of GA lesions to decrease
Smokers more likely to experience vision loss
Research indicates smoking increases risk of AMD, cataracts and glaucoma
Children with amblyopia have increased risk of serious diseases as adults
Investigators emphasised that the data does not indicate a causal relationship between the eye disorder and systemic diseases
Where women stand: A progress report on gender equity in ophthalmology
Mentorship, leadership and addressing bias are key areas for improvement
OCT retinal scans show the eye-kidney connection
The kidney and eye are structurally similar and the diseases of the organs may present via common pathways
Translocated gut bacteria possible cause of some inherited eye diseases
The authors suggested genetic mutation may relax the body’s defences and allow harmful bacteria to reach the eye
OrthoK lenses: Possible long-term axial length shortening for myopic patients
Patient age is significant in the long-term effect of orthokeratology lenses
Extracellular vesicles could be the future of retinal diseases
How this treatment paradigm could change ocular cell therapy
Voyager study provides data on real-world effectiveness of faricimab for nAMD and DME
Robyn Guymer, MBBS, PhD, reported the Voyager study’s preliminary data at the 2024 Angiogenesis, Exudation, and Degeneration conference
Angiogenesis 2024: Distinguishing aspects of early-onset AMD
EODM may be an ideal candidate for development of complement gene therapy due to the high-impact genetic variants
Multimodal assessment of OCT adds perspective on GA and AMD progression
Researchers aimed to develop a translational map to understand how advanced imaging biomarkers manifest in typical diagnostic imaging
AI ocular screenings facilitate early intervention for paediatric patients
Enhanced detection and diagnosis of common and severe diseases
Plan your day: afternoon sessions at the Angiogenesis, Exudation, and Degeneration 2024 Conference
The afternoon sessions begin after lunch and continue well into the evening at the Angiogenesis, Exudation, and Degeneration 2024 meeting
Angiogenesis, Exudation and Degeneration Conference: A 1-day virtual symposium of all things retina
The one-day event will be held online Saturday, February 3, 2024, and is sponsored by the Bascom Palmer Eye Institute, University of Miami Health System
Corneas harvested from patients who died of drowning are viable for transplantation
Postoperative outcomes of the tissues obtained from these donors were satisfactory
Intra-anterior chamber anti-VEGF injections feasible treatment for advanced paediatric vitreoretinal diseases
Investigators advised that further studies should be conducted to understand more precisely the benefits and risks
NEI shares outcomes from workshop on cerebral/cortical visual impairment
Clinicians, researchers and stakeholders discussed establishing CVI diagnostic criteria, boosting awareness of CVI and creating a participant data registry
Faricimab for nAMD and DME: Welcome to the real world
Real-world data from using faricimab to treat neovascular age-related macular degeneration (nAMD) and diabetic macular oedema (DME)
Cannabis use carries no risk of primary open-angle glaucoma
Analysis suggested no evidence for a causal association of lifetime cannabis use and cannabis use disorder with primary open-angle glaucoma
Collaborative rheumatologic–ophthalmologic teams could improve management of patients with rheumatic diseases
Austrian investigators recommend an interdisciplinary, rheumatologic–ophthalmologic approach to disease management
New research data reflect patient satisfaction following faricimab treat-and-extend regimen
A retrospective observational study shows BCVA was maintained after 6 months for patients with neovascular AMD
Novel 3D-printed device may offer a new method to test pharmaceuticals
Moving toward eliminating drug and chemical safety testing in animals
First post-mortem study of human eyes injected with AAV2-based gene therapy for LHON
Bilateral distribution of the transgene seen with unilateral injection
AAO 2023: Analysis of pegcetacoplan for cost-effective treatment of geographic atrophy
Investigators sought to estimate the costs of treating GA with pegcetacoplan and to identify possible utility measures to compare treatments for GA
AAO 2023: Causes and care of paediatric macular holes
Data demonstrated that spontaneous macular hole closure and surgical treatment in paediatric patients appeared to be associated with comparable rates of closure and visual outcomes
AAO 2023: Phase 3 LYNX-1 trial data show phentolamine ophthalmic solution improves low-contrast night vision
Researchers conducted a study on 145 patients with night vision problems, testing the effects of 0.75% phentolamine ophthalmic solution